BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11076310)

  • 1. Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice.
    Gur I; Or R; Segel MJ; Shriki M; Izbicki G; Breuer R
    Exp Lung Res; 2000; 26(7):521-34. PubMed ID: 11076310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
    Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis.
    Segel MJ; Izbicki G; Cohen PY; Or R; Christensen TG; Wallach-Dayan SB; Breuer R
    Am J Physiol Lung Cell Mol Physiol; 2003 Dec; 285(6):L1255-62. PubMed ID: 12857673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin.
    Chen ES; Greenlee BM; Wills-Karp M; Moller DR
    Am J Respir Cell Mol Biol; 2001 May; 24(5):545-55. PubMed ID: 11350823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene C4 aggravates bleomycin-induced pulmonary fibrosis in mice.
    Hirata H; Arima M; Fukushima Y; Sugiyama K; Tokuhisa T; Fukuda T
    Respirology; 2013 May; 18(4):674-81. PubMed ID: 23432979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peribronchial lymphocyte activation in bleomycin-induced lung injury.
    Lossos IS; Breuer R; Shriki M; Or R
    Life Sci; 1998; 63(13):1183-93. PubMed ID: 9763213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis.
    Baecher-Allan CM; Barth RK
    Reg Immunol; 1993; 5(3-4):207-17. PubMed ID: 7694632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A upmodulates bleomycin-induced pulmonary fibrosis in BALB/c mice.
    Lossos IS; Or R; Ginzburg V; Christensen TG; Mashriki Y; Breuer R
    Respiration; 2002; 69(4):344-9. PubMed ID: 12169749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury.
    Berkman N; Kremer S; Or R; Lossos IS; Christensen TG; Goldstein RH; Breuer R
    Respiration; 2001; 68(2):169-77. PubMed ID: 11287832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell independence of bleomycin-induced pulmonary fibrosis.
    Helene M; Lake-Bullock V; Zhu J; Hao H; Cohen DA; Kaplan AM
    J Leukoc Biol; 1999 Feb; 65(2):187-95. PubMed ID: 10088601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXC chemokine receptor 3 modulates bleomycin-induced pulmonary injury via involving inflammatory process.
    Gao JM; Lu B; Guo ZJ
    Chin Med Sci J; 2006 Sep; 21(3):152-6. PubMed ID: 17086735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 attenuates bleomycin-induced pulmonary fibrosis.
    Keane MP; Belperio JA; Burdick MD; Strieter RM
    Am J Physiol Lung Cell Mol Physiol; 2001 Jul; 281(1):L92-7. PubMed ID: 11404251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell-derived transforming growth factor-beta in bleomycin-induced pulmonary injury.
    Kumar RK; O'Grady R; Maronese SE; Wilson MR
    Int J Exp Pathol; 1996 Jun; 77(3):99-107. PubMed ID: 8774378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury.
    Sharma SK; MacLean JA; Pinto C; Kradin RL
    Am J Respir Crit Care Med; 1996 Jul; 154(1):193-200. PubMed ID: 8680680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis.
    Segawa S; Goto D; Iizuka A; Kaneko S; Yokosawa M; Kondo Y; Matsumoto I; Sumida T
    Clin Exp Immunol; 2016 Sep; 185(3):348-60. PubMed ID: 27083148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
    Harrison JH; Lazo JS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury.
    Segel MJ; Aqeilan R; Zilka K; Lorberboum-Galski H; Wallach-Dayan SB; Conner MW; Christensen TG; Breuer R
    Int J Exp Pathol; 2005 Oct; 86(5):279-88. PubMed ID: 16191100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice].
    Wang SJ; Bai W; Wang CL; Dai Z
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2623-7. PubMed ID: 18338602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of bleomycin-induced lung fibrosis.
    Izbicki G; Segel MJ; Christensen TG; Conner MW; Breuer R
    Int J Exp Pathol; 2002 Jun; 83(3):111-9. PubMed ID: 12383190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.